Concourse Financial Group Securities, Inc. Petros Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.64 Billion
  • Q3 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$0.47 - $5.1 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$0.68 - $1.49 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$1.07 - $3.36 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$1.33 - $4.09 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$1.82 - $3.2 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.87 - $4.11 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$2.85 - $4.6 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$3.24 - $4.68 $0 - $0
0 New
0 $0

About Petros Pharmaceuticals, Inc.

PTPI Quotes by TradingView
  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $5.18M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email